Association of remimazolam with delirium and cognitive function: A systematic review and meta-analysis of randomised controlled trials
- PMID: 39698854
- DOI: 10.1097/EJA.0000000000002107
Association of remimazolam with delirium and cognitive function: A systematic review and meta-analysis of randomised controlled trials
Abstract
Background and study objective: Delirium is an organic mental syndrome significantly associated with long-term cognitive decline, increased hospital stays and higher mortality. This systematic review of randomised controlled trials (RCTs) with meta-analysis assesses the association of remimazolam with postoperative cognitive function and delirium compared with non-benzodiazepine hypnotics.
Design: Systematic review of RCTs with meta-analysis.
Data sources: PubMed, Embase, Cochrane Library and Web of Science databases up to 27 April 2024.
Eligibility criteria: Adult patients undergoing general anaesthesia or sedation procedures; use of remimazolam as the primary hypnotic or as an adjunct, administered via intermittent bolus or continuous infusion; comparison with other hypnotics or sedatives; evaluation of cognitive function or delirium.
Main results: Twenty-three RCTs with 3598 patients were included. The incidence of delirium was not significantly different between remimazolam and other sedatives in general anaesthesia and sedation procedures [ n = 3261; odds ratio (OR) = 1.2, 95% confidence interval (CI), 0.76 to 1.91; P = 0.378843; I2 = 17%]. Regarding cognitive function evaluation, remimazolam showed no difference compared with the control group in Mini-Mental State Examination (MMSE) scores on the first postoperative day ( n = 263; mean difference = 0.60, 95% CI, -1.46 to 2.66; P = 0.5684; I2 = 90%) or on the third postoperative day ( n = 163; mean difference = 1.33, 95% CI, -0.72 to 3.38; P = 0.2028; I2 = 93%). Remimazolam exhibited superiority over the control group in MMSE scores on the seventh postoperative day ( n = 247; mean difference = 0.53, 95% CI, 0.30 to 0.75; P < 0.0001; I2 = 28%).
Conclusion: Remimazolam does not increase the incidence of delirium or cognitive impairments compared with non-benzodiazepine hypnotics. However, the analysis showed that the type of surgery significantly influenced the incidence of delirium. Additionally, remimazolam was associated with better short-term postoperative cognitive function.
Systematic review registration: PROSPERO CRD42024532751.
Copyright © 2024 European Society of Anaesthesiology and Intensive Care. Unauthorized reproduction of this article is prohibited.
Similar articles
-
Association of remimazolam with delirium and cognitive function in elderly patients undergoing general anesthesia or procedural sedation: a meta-analysis of randomized controlled trials.Front Med (Lausanne). 2025 Apr 28;12:1567794. doi: 10.3389/fmed.2025.1567794. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40357277 Free PMC article.
-
Effect of remimazolam on postoperative delirium and cognitive function in adults undergoing general anesthesia or procedural sedation: a meta-analysis of randomized controlled trials.Korean J Anesthesiol. 2025 Apr;78(2):118-128. doi: 10.4097/kja.24493. Epub 2025 Jan 3. Korean J Anesthesiol. 2025. PMID: 39748753 Free PMC article.
-
Postoperative delirium under general anaesthesia by remimazolam versus propofol: A systematic review and meta-analysis of randomised controlled trials.J Clin Anesth. 2025 Feb;101:111735. doi: 10.1016/j.jclinane.2024.111735. Epub 2024 Dec 30. J Clin Anesth. 2025. PMID: 39832842
-
Incidence and predictors of postoperative delirium following remimazolam administration: a systematic review and meta-analysis of 29 randomized trials.BMC Anesthesiol. 2025 Apr 23;25(1):201. doi: 10.1186/s12871-025-03018-w. BMC Anesthesiol. 2025. PMID: 40269722 Free PMC article.
-
Remimazolam vs. propofol for induction and maintenance of general anesthesia: A systematic review and meta-analysis of emergence agitation risk in surgical populations.J Clin Anesth. 2025 Apr;103:111815. doi: 10.1016/j.jclinane.2025.111815. Epub 2025 Mar 22. J Clin Anesth. 2025. PMID: 40120546
Cited by
-
Association of remimazolam with delirium and cognitive function in elderly patients undergoing general anesthesia or procedural sedation: a meta-analysis of randomized controlled trials.Front Med (Lausanne). 2025 Apr 28;12:1567794. doi: 10.3389/fmed.2025.1567794. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40357277 Free PMC article.
-
The effects of remimazolam and propofol on delirium following anesthesia and sedation in elderly patients: a systematic review and meta-analysis.BMC Anesthesiol. 2025 Jul 1;25(1):312. doi: 10.1186/s12871-025-03167-y. BMC Anesthesiol. 2025. PMID: 40597651 Free PMC article.
-
What Every Intensivist Should Know About Remimazolam.Indian J Crit Care Med. 2025 Jun;29(6):531-533. doi: 10.5005/jp-journals-10071-24993. Epub 2025 Jun 5. Indian J Crit Care Med. 2025. PMID: 40567326 Free PMC article.
References
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association Publishing; 2022.
-
- Hamilton GM, Wheeler K, Di Michele J, et al. A systematic review and meta-analysis examining the impact of incident postoperative delirium on mortality. Anesthesiology 2017; 127:78–88.
-
- Maldonado JR. Acute brain failure: pathophysiology, diagnosis, management, and sequelae of delirium. Crit Care Clin 2017; 33:461–519.
-
- Goldberg TE, Chen C, Wang Y, et al. Association of delirium with long-term cognitive decline: a meta-analysis. JAMA Neurol 2020; 77:1373–1381.
-
- Zaal IJ, Devlin JW, Hazelbag M, et al. Benzodiazepine-associated delirium in critically ill adults. Intensive Care Med 2015; 41:2130–2137.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous